Reducing radiation exposure during sacral neuromodulation lead placement

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of reduced radiation fluoroscopy settings compared to conventional fluoroscopy during the lead placement for sacral neuromodulation in patients with overactive bladder. Patients scheduled for this procedure will be randomized into two groups: one receiving the experimental reduced radiation settings and the other receiving standard fluoroscopic settings. The primary focus is to compare the radiation exposure between these two groups while ensuring optimal lead placement by the surgeon. The study aims to enhance patient safety by minimizing radiation exposure during this common procedure.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients undergoing lead implantation for sacral neuromodulation that have overactive bladder as defined by urinary urgency, frequency, nocturia with or without urgency incontinence.

Exclusion Criteria:

* neurogenic bladder, BMI \>40, or peripheral neuropathy.

Where it's running

• Loma Linda University Health
  Loma Linda, California, United States Recruiting

Study contacts

• Principal investigator: Forrest Jellison, MD — Loma Linda University
• Study coordinator: Forrest Jellison, MD
• Email: fjellison@llu.edu
• Phone: 909 558-2830

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Shortening the trial time for sacral neuromodulation in treating urinary incontinence

  This study is testing if cutting the trial period for a nerve treatment from 7 days to 3 days can still help women with urinary incontinence feel better before getting a permanent device.

  Recruiting University of Chicago · Chicago, Illinois · NCT06226220

• Evaluation of eCoin for treating urgency urinary incontinence

  This study is testing whether an implanted device called eCoin can help people with urgency urinary incontinence feel better over the long term.

  Recruiting at 19 sites Valencia Technologies Corporation · Homewood, Alabama and 21 other locations · NCT05685433

• Flyte device to help urinary incontinence after pelvic radiation for endometrial or cervical cancer

  This study tests whether a home-use Flyte device, used during guided pelvic floor exercises, can improve urinary incontinence in women who had pelvic radiation for endometrial or cervical cancer.

  Recruiting Mayo Clinic · Rochester, Minnesota · NCT07662824

• Self-Start Macrobid for post-Botox lower urinary symptoms

  This study tests whether giving a standing prescription for Macrobid after Botox treatment reduces urgent calls, messages, and visits for urinary symptoms compared with usual triage care.

  Recruiting Early Phase 1 The Cleveland Clinic · Cleveland, Ohio · NCT07648290

• Next-Gen Fluoroscopy System vs Conventional System in Endoscopy

  This trial tests whether a next-generation fluoroscopy system lowers radiation exposure for patients and staff during fluoroscopy-guided endoscopic procedures.

  Recruiting Orlando Health, Inc. · Orlando, Florida · NCT07594132

• Operator radiation dose during PCI: left distal radial access vs right conventional radial access

  This study tests whether using the left distal radial approach during PCI leads to different radiation exposure for the operator compared with the standard right radial approach in adult patients.

  Recruiting Yonsei University · Osaka and 3 other locations · NCT07579169

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.